Bill Text: NY K00067 | 2021-2022 | General Assembly | Introduced


Bill Title: Memorializing Governor Andrew M. Cuomo to proclaim February 28, 2021, as Rare Disease Day in the State of New York

Spectrum: Bipartisan Bill

Status: (Passed) 2021-02-24 - adopted [K00067 Detail]

Download: New_York-2021-K00067-Introduced.html

Assembly Resolution No. 67

BY: M. of A. McDonald

        MEMORIALIZING Governor Andrew M. Cuomo to proclaim
        February  28, 2021, as Rare Disease Day in the State
        of New York

  WHEREAS, It is the custom of  this  Legislative  Body  to  recognize
official  days  set  aside  to increase awareness of serious issues that
affect the lives of citizens of New York State; and

  WHEREAS, Attendant to such concern, and  in  full  accord  with  its
long-standing  traditions,  it  is the sense of this Legislative Body to
memorialize Governor Andrew M. Cuomo to proclaim February 28,  2021,  as
Rare Disease Awareness Day in the State of New York, in conjunction with
the observance of National Rare Disease Day; and

  WHEREAS,  National  Rare  Disease  Day  is  an  observance  to raise
awareness of rare diseases and diseases of unmet need, few of which have
cures or specific drugs to treat symptoms, and are often  not  diagnosed
for many years; and

  WHEREAS,  2021 marks the 13th Anniversary of Rare Disease Day in the
United States; the first Rare Disease Day was held in 2008  on  February
29th, a 'rare' date which happens only once every four years; ever since
then,  Rare  Disease  Day has taken place on the last day of February, a
month known for having a 'rare' number of days; and

  WHEREAS, Rare Disease Day was established for the reason,  according
to   the  European  Organization  for  Rare  Diseases  (EURORDIS),  that
treatment  for  many  rare  diseases  and  diseases  of  unmet  need  is
insufficient,  as  are  the  social networks to support individuals with
rare diseases and diseases of unmet need and their families; and

  WHEREAS, One year later, in 2009, Rare Disease Day  went  global  as
the  National  Organization  of Rare Disorders (NORD) mobilized 200 rare
disease patient advocacy organizations in the United States in an effort
to coordinate activities and better promote the day; and

  WHEREAS, In 2013, in recognition of the needs of patients with  rare
diseases,  Albany  Medical  Center  and  College  established the Albany
Medical Center's Rare Disease Forum, which was the genesis  of  the  New
York  State  Rare  Disease  Alliance, whose purpose is to promote faster
diagnosis of rare diseases, research into therapies and  cures,  and  to
foster  wider  public  recognition  of  public health problems affecting
25-30 million Americans; 1 in 10 New Yorkers suffer from a rare disease;
and

  WHEREAS, There are nearly 7,000 diseases and  conditions  considered
rare,  each  year  affecting  approximately  25-30 million Americans and
1-in-10 individuals in New York State has a known rare diseases; and

  WHEREAS, Of these 7,000 rare diseases, more than 95% are without FDA
approved treatment; and

  WHEREAS, Since many rare diseases and diseases  of  unmet  need  are
genetic,  tragically,  approximately  half  the  people affected by rare
diseases in the United States are children; and

  WHEREAS,  Research  on  rare  diseases,  which are serious and often
life-threatening,  is  vitally  important  due  to  it  frequently  adds
significantly  to  the general understanding of more common diseases and
conditions; and

  WHEREAS, People suffering from rare  diseases  typically  experience
difficulty in obtaining a timely, accurate diagnosis, finding physicians
or  treatment  centers and experience limited treatment options, options
generally considered more expensive than those for common diseases; and

  WHEREAS, It takes between six to eight years on average  to  receive
an accurate diagnosis; and

  WHEREAS, Biopharmaceutical research companies, academic researchers,
patient groups, and others are applying the growing understanding of the
causes  of  rare diseases to speed the development of new treatments for
patients; the Orphan Drug Act of 1983 has been and continues  to  be  an
important force in driving treatment innovation for rare diseases; and

  WHEREAS,  Advances  in DNA sequencing have led to the identification
of the genetic cause of several rare disease, which can potentially lead
to better understanding of  the  disease  and  development  of  targeted
therapies; and

  WHEREAS,  Today,  there  is more hope than ever before with over 560
medicines in development for patients with rare diseases;  medicines  in
development  include 151 for rare cancers and 82 for rare blood cancers,
accounting for 40 percent of all rare disease medicines in  development;
148 for genetic disorders, including cystic fibrosis and spinal muscular
atrophy;  38  for  neurological disorders, including amyotrophic lateral
sclerosis (ALS) and seizures; 31 for infectious diseases, including rare
bacterial  infections  and  hepatitis;  25  for   autoimmune   diseases,
including systemic sclerosis and juvenile arthritis; and

  WHEREAS,  Currently,  research  has led to powerful new gene-editing
techniques holding promise for cures for blood disorders (such as Sickle
Cell  Disease,  Thalassemia,  Hemophilia),  Cancer,   Blindness,   Aids,
Muscular Dystrophy, Cystic Fibrosis, and Huntington's disease; and

  WHEREAS, These treatment options and medicines in development attack
the  root  of  the cause for these patients that had few or no treatment
options before; and

  WHEREAS, In 2019, legislation creating a Rare Disease Advisory  Work
Group  was  signed  into  law;  this  Work  Group  will  be  composed of
individuals with expertise in  rare  disease  who  will  focus  on  best
practices  that will:   improve awareness of rare diseases; refer people
with potential rare diseases to specialists;  and evaluate  barriers  to
treatment including financial barriers on access to care; and

  WHEREAS,  It is imperative that there be greater public awareness of
rare diseases and diseases of unmet need,  and  more  must  be  done  to
increase  activity  at  the  local, state and national levels to support

those  afflicted  as  well  as  their  families  and  caregivers;   now,
therefore, be it

  RESOLVED,  That  this Legislative Body pause in its deliberations to
memorialize Governor Andrew M. Cuomo to proclaim February 28,  2021,  as
Rare  Disease  Day  in  the  State  of New York, in conjunction with the
observance of National Rare Disease Day; and be it further

  RESOLVED, That copies of this  Resolution,  suitably  engrossed,  be
transmitted  to  The Honorable Andrew M. Cuomo, Governor of the State of
New York; the New York State Rare Disease Alliance; and NORD.
feedback